BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 27, 2018
Company News

Lee's mulls spin off, HK IPO for China oncology subsidiary

Read More
BioCentury | Dec 1, 2017
Company News

Shenogen, Lee's forge another cancer combo deal

Read More
BioCentury | Nov 20, 2017
Company News

Shenogen, Lee's forge another cancer combo deal

Read More
BioCentury | Aug 18, 2017
Clinical News

Transgene starts Phase I/IIa of Pexa-Vec plus Opdivo for HCC

Read More
BioCentury | Apr 13, 2017
Clinical News

Pexa-Vec: Ph I/II METROmaJX ongoing

Read More
BioCentury | Feb 16, 2017
Clinical News

Pexa-Vec: Ph I ISI-JX started

Read More
BioCentury | Aug 24, 2016
Company News

Lee's, Shenogen to develop cancer combo therapy

Read More
BioCentury | Mar 25, 2016
Financial News

SillaJen raises $37M in venture round

Read More
BioCentury | Jan 18, 2016
Clinical News

Pexa-Vec pexastimogene devacirepvec: Phase III started

Read More
BioCentury | Jul 27, 2015
Clinical News

Pexastimogene devacirepvec: Additional Phase Ib data

Read More
Items per page:
1 - 10 of 51